Search results for "Biotech; process development; event"
Article
Setting Standards for Biotech Therapeutics in India
The authors take a look at the past and future impact of the Indian Pharmacopoeia Commission.
By: Anurag S. Rathore, PhD, Renu Jain, M. Kalaivani, Gunjan Narula, G. N. Singh
BioPharm Inter…
Article
Cytiva seminar Milano: Accelerate biotech process development
Seminar close to Milano!
Biopharmaceutical process development faces new challenges: shorter time-to-market and changing regulatory expectations for new molecular entities. Implementing…
Webcast
Biotech Makers: Tools and top tips for faster process development
Listen to speakers from Byondis and Cytiva in our first 'Biotech Makers Workshops' event on the 30th March (2pm CET).
We will discuss top tips and tools for faster process development to help you a…
Article
Biotech Makers: Tools and top tips for faster process development
Listen to speakers from Byondis and Cytiva in our first 'Biotech Makers Workshops' event on the 30th March (2pm CET).
We will discuss top tips and tools for faster process developme…
Article
Cytiva Seminar Barcelona: Accelerate Biotech Process Development
Seminar in Barcelona!
Biopharmaceutical process development faces new challenges: shorter time-to-market and changing regulatory expectations for new molecular entities. Implementing tool…
Webcast
Biotech Makers: Solving challenges in process development of a diversifying antibody pipeline
The therapeutic pipeline for antibodies continues to diversify into new modalities including bi-specific, tri-specific, antibody fragments and domain antibodies which bring new challenges to process…
Webcast
Cytiva Seminar Milano: Accelerate Biotech Process Development
Biopharmaceutical process development faces new challenges: shorter time-to-market and changing regulatory expectations for new molecular entities. Implementing tools and solutions are essential for o…
Webcast
Cytiva Seminar Barcelona: Accelerate Biotech Process Development
Biopharmaceutical process development faces new challenges: shorter time-to-market and changing regulatory expectations for new molecular entities. Implementing tools and solutions are essential for o…
Article
Maximum Output Starts with Optimized Upstream Processing
By Cynthia A. Challener
Biopharmaceutical companies and contract manufacturers respond to changing demand dynamics for upstream bioprocessing capacity.
Significant growth in the develo…
Article
A Risk-Based Genetic Characterization Strategy for Recombinant CHO Cell Lines Used for Clinical and Commercial Applications
The authors describe the ways in which manufacturers can mitigate the risks related to the integrity of recombinant transgenes expressed in CHO cells.
By Luhong He, Christopher Frye
Abstract
…